Bangerter, Abigail http://orcid.org/0000-0002-9360-3411
Ness, Seth
Lewin, David
Aman, Michael G.
Esbensen, Anna J.
Goodwin, Matthew S.
Dawson, Geraldine
Hendren, Robert
Leventhal, Bennett
Shic, Fred
Opler, Mark
Ho, Kai Fai
Pandina, Gahan
Funding for this research was provided by:
Janssen Research and Development, LLC, USA
Article History
First Online: 19 March 2019
Compliance with Ethical Standards
:
: Seth Ness and Gahan Pandina are employees of Janssen Research & Development, LLC and hold company stocks/stock options. Anna Esbensen has consulted with Roche on outcome measures in Down syndrome and ProPhase LLC. Robert Hendren received reimbursement for consultation from Janssen Research & Development, LLC. Michael Aman has received research contracts, consulted with, served on advisory boards, or done investigator training for AMO Pharma, Bracket, CogState, Inc., CogState Clinical Trials, Ltd., Coronado Biosciences, Forest Research, Hoffman-La Roche, Lumos Pharma, MedAvante, Inc., Ovid Therapeutics; ProPhase LLC, Supernus Pharmaceuticals, Zynerba Pharmaceuticals, and Yamo Pharmaceuticals. He receives royalties from Slosson Educational Publications. Geraldine Dawson is on the Scientific Advisory Boards of Janssen Research and Development, LabCorp, and Akili, Inc., a consultant to Roche; has received grant funding from Janssen Research and Development, LLC and PerkinElmer; and, receives royalties from Guilford Press and Oxford University Press.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.